Kolexia
Vinatier Isabelle Anesthesie-réanimation
Vinatier Isabelle
Anesthesie-réanimation
Centre Hospitalier Départemental Vendée
La Roche-sur-Yon, France
44 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie grave Choc Infection croisée Choc septique Pneumopathie infectieuse Hypothermie COVID-19 Arrêt cardiaque Sepsie

Collaborateurs

Voir plus
Renault Anne
Renault Anne
Hôpital Cavale Blanche, Brest, France
Rigaud Jean-Philippe
Rigaud Jean-Philippe
Centre Hospitalier de Dieppe, Dieppe, France
Mercier Emmanuelle
Mercier Emmanuelle
Centre hospitalier de Tours, Tours, France
Argaud Laurent
Argaud Laurent
Hôpital Edouard Herriot, Lyon, France

Industries

Voir plus
Baxter
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Psychic trauma and resilience process of patients after severe critical illness requiring mechanical ventilation: the Resirea study
Proceedings of Reanimation 2023, the French Intensive Care Society International Congress   14 juin 2023
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.
The Lancet. Respiratory medicine   31 mai 2023
ASTONISH: Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock. A Randomized, Double-blind, Placebo Controlled Dose Selection Study
Essai Clinique (Inotrem)   07 avril 2023
Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).
The Lancet. Respiratory medicine   20 mars 2023
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial.
JAMA   22 avril 2022
NUTRIREA3: Impact of Early Low-Calorie Low-Protein Versus Standard-Calorie Standard-Protein Feeding on Outcomes of Ventilated Adults With Shock: a Randomised, Controlled, Multicentre, Open-label, Parallel-group Study (NUTRIREA-3)
Essai Clinique (CHU Nantes)   05 avril 2022
Oxygenation Strategy During Acute Respiratory Failure in Critically-Ill Immunocompromised Patients.
Critical care medicine   25 mai 2021
Impact of early low-calorie low-protein versus standard-calorie standard-protein feeding on outcomes of ventilated adults with shock: design and conduct of a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).
BMJ open   11 mai 2021
SEPSIS-ACT: A Double-blind, Randomised, Placebo-Controlled, Phase 2b/3 Adaptive Clinical Trial Investigating the Efficacy and Safety of Selepressin as Treatment for Patients With Vasopressor-dependent Septic Shock
Essai Clinique (Ferring)   11 mars 2021
Assessing physicians' and nurses' experience of dying and death in the ICU: development of the CAESAR-P and the CAESAR-N instruments.
Critical care (London, England)   25 août 2020